These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2523285)

  • 21. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
    Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.
    Endo A; Nagai N; Urano T; Ihara H; Takada Y; Hashimoto K; Takada A
    Neurosci Lett; 1998 Apr; 246(1):37-40. PubMed ID: 9622202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator and its inhibitor in the experimental corneal wound.
    Tervo T; Tervo K; van Setten GB; Virtanen I; Tarkkanen A
    Exp Eye Res; 1989 Mar; 48(3):445-9. PubMed ID: 2494049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.
    Bizik J; Lizonová A; Stephens RW; Grófová M; Vaheri A
    Cell Regul; 1990 Nov; 1(12):895-905. PubMed ID: 1712633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activation in healing human wounds.
    Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
    Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoradiographic and immunoblotting analyses of the activation pathways of plasminogen by urokinase and tissue plasminogen activator in the plasma or clotted plasma.
    Takada A; Yoshida M; Takada Y
    Thromb Res; 1988 Jan; 49(2):193-204. PubMed ID: 3129815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
    Ts'ao C; Galluzzo TS
    Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
    Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
    Castro MJ; Kingston IB; Anderson S
    Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmin and plasminogen activators: kinetics, and kinetics of plasminogen activation.
    Robbins KC; Wohl RC; Summaria L
    Ann N Y Acad Sci; 1981; 370():588-91. PubMed ID: 6455955
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasminogen activation system in human milk.
    Heegaard CW; Larsen LB; Rasmussen LK; Højberg KE; Petersen TE; Andreasen PA
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):159-66. PubMed ID: 9252902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
    Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
    Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activator system in pemphigus vulgaris.
    Schaefer BM; Jaeger CJ; Kramer MD
    Br J Dermatol; 1996 Nov; 135(5):726-32. PubMed ID: 8977672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oocytes use the plasminogen-plasmin system to remove supernumerary spermatozoa.
    Coy P; Jiménez-Movilla M; García-Vázquez FA; Mondéjar I; Grullón L; Romar R
    Hum Reprod; 2012 Jul; 27(7):1985-93. PubMed ID: 22556378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activation in psoriasis.
    Lotti T; Bonan P; Panconesi E
    Acta Derm Venereol Suppl (Stockh); 1989; 146():36-8. PubMed ID: 2514542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.